Assessment of Comorbidity in Bariatric Patients through a Biomarker-Based Model-A Multicenter Validation of the Metabolic Health Index.
Carmen GensenSaskia L M van LoonNatal A van RielSimon NienhuijsRalf TriepelsSnjezana KosAlide H L MulderNadine PouwVolkher ScharnhorstArjen Kars BoerPublished in: The journal of applied laboratory medicine (2022)
The MHI model can be applied in clinical practice of bariatric centers, regardless of patient mix and analytical platform. Because the MHI is based on objective parameters, it is insensitive to diverging clinical definitions of comorbidities. Therefore, the MHI can be used to objectify severity of metabolic comorbidities in bariatric patients. The MHI can support the patient-selection process for surgery and objectively assessing the effect of surgery on the metabolic health state.
Keyphrases
- end stage renal disease
- healthcare
- public health
- ejection fraction
- minimally invasive
- weight loss
- clinical practice
- mental health
- peritoneal dialysis
- roux en y gastric bypass
- prognostic factors
- physical activity
- coronary artery bypass
- coronary artery disease
- cross sectional
- health information
- liquid chromatography
- human health
- climate change
- percutaneous coronary intervention
- mass spectrometry